Folic acid-conjugated biopolymeric nanoparticles for targeted delivery of ixabepilone in breast cancer
- 9 February 2026
- journal article
- Published by Taylor & Francis in Preparative Biochemistry & Biotechnology
- Vol. 56 (9) , 1-16
Abstract
Ixabepilone (IXA) is an FDA-approved chemotherapeutic agent for metastatic breast cancer; however, its clinical use is limited by severe toxicity to healthy tissues. To improve its therapeutic index, tumor-targeted drug delivery systems are required. In this study, IXA was encapsulated for the first time into folic acid (FA)-functionalized biopolymeric nanoparticles (NPs) to promote preferential delivery to folate receptor (FR)-expressing breast cancer cells. Chitosan (CS) and alginate (ALG) were conjugated with FA to fabricate targeted NP systems, and IXA-loaded formulations were optimized in terms of encapsulation efficiency and particle size. The optimized IXA/FACS and IXA/FAALG NPs exhibited encapsulation efficiencies of 51.3 ± 4.6% and 47.6 ± 5.0%, with mean particle sizes of approximately 155 nm. In vitro release studies under physiological and tumor-mimicking pH conditions demonstrated pH-responsive behavior, with increased IXA release at acidic pH (5.5). Release kinetics analysis indicated diffusion-controlled and anomalous transport mechanisms according to the Higuchi and Korsmeyer-Peppas models. Cytotoxicity studies on MDA-MB-231 and MCF-7 breast cancer cell lines revealed enhanced cytotoxic effects of FA-conjugated IXA-loaded NPs in FR-positive MDA-MB-231 cells compared to MCF-7 cells, suggesting preferential FR-mediated cellular interaction. Overall, FA-functionalized CS and ALG NPs represent a promising in vitro platform for targeted IXA delivery in FR-expressing breast cancer therapy.Keywords
Funding Information
- Ege University Office of Scientific Research Projects (Multi-Disciplinary Priority Area Research Project (23821)
This publication has 75 references indexed in Scilit:
- Cancer statistics for the year 2020: An overviewInternational Journal of Cancer, 2021
- Electrospun Nanofibers for Dual and Local Delivery of Neuroprotective DrugsFibers and Polymers, 2021
- Synthesis of folate- pegylated polyester nanoparticles encapsulating ixabepilone for targeting folate receptor overexpressing breast cancer cellsJournal of Materials Science: Materials in Medicine, 2015
- Mechanism of action of ixabepilone and its interactions with the βIII-tubulin isotypeCancer Chemotherapy and Pharmacology, 2015
- Application of microwave‐assisted click chemistry in the preparation of functionalized copolymers for drug conjugationJournal of Applied Polymer Science, 2012
- Preparation, characterization, and in vitro release of folic acid-conjugated chitosan nanoparticles loaded with methotrexate for targeted deliveryPolymer Bulletin, 2011
- Evaluation of cytotoxicity and mechanism of apoptosis of doxorubicin using folate-decorated chitosan nanoparticles for targeted delivery to retinoblastomaCancer Nanotechnology, 2010
- Preclinical discovery of ixabepilone, a highly active antineoplastic agentCancer Chemotherapy and Pharmacology, 2008
- The EPR Effect and Polymeric Drugs: A Paradigm Shift for Cancer Chemotherapy in the 21st Century2005
- Hydrophobically Associating Alginate Derivatives: Surface Tension Properties of Their Mixed Aqueous Solutions with Oppositely Charged SurfactantsJournal of Colloid and Interface Science, 2000